Obtaining a recombinant strain – Pichia pastoris – a producer of the gp51 protein of the bovine leukemia virus
Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya · 2026 · (73) · 36-55
DOI: 10.17223/19988591/73/2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya, 2026. Verfasst von Konstantin V. Usoltsev und 7 weiteren Autor:innen.
Abstract (Originalsprache)
The reaction of immune diffusion in agar gel and enzyme immunoassay are laboratory methods that form the basis of preventive measures in the fight against bovine leukaemia. Virus obtained using culture of sheep embryo kidney cells (FLK) is commonly used as an antigen in diagnostic test systems for detecting markers of bovine leukaemia virus. However, this cell culture is frequently contaminated with the causative agent of viral diarrhoea, which can lead to false-positive test results. Furthermore, obtaining antigen using cell cultures is an expensive and time-consuming process. The use of recombinant synthesis technology offers a solution to these issues. This work was aimed to create a recombinant strain of the yeast Pichia pas-toris that synthesises the gp51 protein of bovine leukaemia virus. To obtain the recombinant protein using yeast cells, a synthesised nucleotide sequence of the bovine leukaemia virus gp51 gene was employed. The genetic code sequence was optimised for P. pastoris codon usage, and SacII restriction sites, thymidine-5-phosphate nucleotides, and a stop codon were added. As a result, the modified sequence was 919 base pairs in length (See Fig. 1). The amino acid sequence of the developed recombinant complex protein, comprising the yeast secretion signal factor a and the bovine leukaemia virus gp51 glycoprotein, consists of 406 amino acids and has a molecular weight of 45.7 kDa (See Fig. 2). After synthesis, the nucleotide sequence was cut at the 5' and 3' ends using the Sacll restriction endonuclease and inserted into the pFLDa plasmid vector. The resulting recombinant plasmid is a covalently closed circular doublestranded DNA molecule, 5607 base pairs in length (See Fig. 3). Synthesis plasmids were produced using the following technique. First, the plasmid was transformed into Escherichia coli strain TOP10 cells, using calcium chloride, according to the protocol of Ausubel (2003), with selection for ampicillin resistance gene and subsequent isolation and purification of plasmid DNA. The concentration of the isolated plasmid was 242 ng. The isolated plasmid was visualised using horizontal electrophoresis in 1.5% agarose gel. It was determined that the modified plasmid had a greater molecular weight than the similar plasmid without the insert. Following electroporation of P. pastoris cells with the linearised plasmid, a recombinant P. pastoris strain was obtained. The P. pastoris yeast cells were cultured on MMA (with methanol) and MGMa (with methylamine) expression media. The presence of the recombinant protein gp51 in yeast strain cells was assessed using 12% SDS-PAGE electrophoresis. The presence of the recombinant protein gp51 in yeast strain cells was assessed using 12% SDS-PAGE electrophoresis. Protein synthesis was detected in all analysed culture fluid samples, with a molecular weight corresponding to the theoretically expected 45.7 kDa. Similar patterns were observed on the electropherogram when the recombinant P. pastoris strain was grown on both MMAs (with methanol) and MGMa (with methylamine) media, indicating comparable levels of protein synthesis on both substrates (See Fig. 4). The antigenic affinity of the synthesised protein with bovine leukaemia virus proteins was demonstrated using Western blot analysis, as it reacts with specific immunoglobulins against the causative agent of enzootic leukaemia (See Fig. 5). The antigenic affinity of the recombinant protein was also confirmed by enzyme immunoassay. The interaction between the recombinant antigen and specific antiviral immunoglobulins was demonstrated. The minimum dilution of the positive control blood serum at which the positivity coefficient (P) exceeded two was 1 : 800 (See Table 1 ). The recombinant yeast strain P. pastoris produces the surface antigen of the causative agent of bovine leukaemia, fused to the a-factor yeast secretion signal. These results are of considerable practical significance, as they demonstrate the potential use of the engineered P. pastoris strain for synthesising a recombinant viral antigen. This antigen could serve as a component in serological test systems for detecting antibodies against the bovine leukaemia virus. The article contains 5 Figures, 1 Table, and 33 References. The Authors declare no conflict of interest.
Zitieren
APA
Usoltsev, K. V., Gorbunova, M. Е., Skvortsov, E. V., Validov, S. Z., Alexandrova, N. M., Shangaraev, R. I., Osyanin, K. A., & Khammadov, N. I. (2026). Obtaining a recombinant strain – Pichia pastoris – a producer of the gp51 protein of the bovine leukemia virus. Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya, 36-55. https://doi.org/10.17223/19988591/73/2
Vancouver
Usoltsev KV, Gorbunova MЕ, Skvortsov EV, Validov SZ, Alexandrova NM, Shangaraev RI, et al. Obtaining a recombinant strain – Pichia pastoris – a producer of the gp51 protein of the bovine leukemia virus. Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya. 2026:36-55. doi:10.17223/19988591/73/2
BibTeX
@article{Usoltsev2026,
author = {Usoltsev, Konstantin V. and Gorbunova, Maria Е. and Skvortsov, Evgeny V. and Validov, Shamil Z. and Alexandrova, Natalia M. and Shangaraev, Rafkat I. and Osyanin, Konstantin A. and Khammadov, Nail I.},
title = {Obtaining a recombinant strain – Pichia pastoris – a producer of the gp51 protein of the bovine leukemia virus},
journal = {Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya},
year = {2026},
number = {73},
pages = {36--55},
doi = {10.17223/19988591/73/2}
}
EUVIMED